New drug combo aims to control advanced cancers
Disease control
Recruiting now
This early-phase study tests a new drug called LB-LR1109 in people with advanced solid tumors like lung, kidney, head and neck, bladder, or skin cancer that has not responded to standard treatments. The study first gives the drug alone, then in combination with another cancer dru…
Phase: PHASE1 • Sponsor: LG Chem • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC